| Financial Year |
March 31 2023 |
| Monetary Funds |
254,479,957.57 |
| Held-for-trading Financial Assets |
655,501,654.28 |
| Notes Receivable |
-- |
| Accounts Receivable |
69,404,076.84 |
| Advances to Suppliers |
200,984,206.98 |
| Other Receivables |
30,746,310.45 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
600,903,010.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,009,753.24 |
| Total Current Assets |
1,818,028,969.36 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
26,725,119.82 |
| Investment Properties |
298,375,076.35 |
| Fixed Assetes |
1,069,038,914.62 |
| Under-construction Projects |
3,755,725.36 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
330,620,817.76 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
13,771,196.67 |
| Deferred Income Tax Assets |
15,902,356.52 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
2,078,542,543.43 |
| Total Assets |
3,896,571,512.79 |
| Short-Term Loans |
99,725,085.20 |
| Trading Financial liabilities |
-- |
| Notes Payable |
457,042,760.00 |
| Accounts Payable |
81,128,787.06 |
| Accounts Received In Advance |
20,437,937.30 |
| Employee Compensation Payable |
78,432,845.63 |
| Taxes Payable |
16,842,271.71 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
383,860,308.65 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
30,696,736.86 |
| Other Current Liabilities |
3,574,523.85 |
| Sub-Total of Current Liabilities |
1,242,079,637.72 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
29,706,613.50 |
| Special Payable |
-- |
| Estimatied Liabilities |
4,777,950.76 |
| Deferred Income Tax Liabilities |
3,617,987.59 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
305,416,297.50 |
| Total Liabilities |
1,547,495,935.22 |
| Paid-In Capital(Or Share Stock) |
390,000,000.00 |
| Capital Surplus |
329,638,599.94 |
| Surplus Reserve |
119,012,068.02 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
741,602,260.48 |
| Minority Stockholder's Interest |
770,322,649.13 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,578,752,928.44 |
| Owner's Equity（Stockholder's Equity） |
2,349,075,577.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,896,571,512.79 |
